Admedus Limited
(ASX:AHZ) has announced it has received FD clearance to market its vascular repair patches.
The company’s launch is scheduled for November of this year, with an initial release of two product sizes only.
The company estimates there are 250,000 vascular repair procedures performed each year, and values the global market at $500 million.
Admedus believes its premium next generation collagen scaffolding technology will allow it to take significant market share.
Ademdus Limited posted a net loss of $25.1 million at 30 June 2016.
